Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.62 USD | +0.23% | +1.17% | -19.62% |
09/05 | Transcript : Oncternal Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Oncternal Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.62% | 2.55Cr | |
+29.03% | 4.92TCr | |
-0.10% | 4.21TCr | |
+49.56% | 4.04TCr | |
-5.26% | 2.89TCr | |
+11.48% | 2.61TCr | |
-22.74% | 1.87TCr | |
+9.06% | 1.33TCr | |
+30.01% | 1.23TCr | |
-1.51% | 1.2TCr |
- Stock Market
- Equities
- ONCT Stock
- News Oncternal Therapeutics, Inc.
- HC Wainwright Downgrades Oncternal Therapeutics to Neutral From Buy